.
MergerLinks Header Logo

Announced

BDT Capital to acquire a majority stake in MJH Life Sciences for $2.5bn.

Financials

Edit Data
Transaction Value£1,861m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

healthcare services

United States

Acquisition

Domestic

Private

Majority

Private Equity

Pending

Friendly

Single Bidder

Media Agencies

Synopsis

Edit

BDT Capital, a private equity firm, agreed to acquire a majority stake in MJH Life Sciences, a full-service medical media company in North America dedicated to delivering trusted health care news across multiple channels, for $2.5bn. “In order to continue to enhance overall engagement between healthcare professionals and pharma, we’ve sought a long-term capital partner to continue to grow our audience reach, and ensure we will continue to provide best-in-class service to our clients well into the future. We have purposefully and diligently selected a partner in BDT who honors our values and competitive spirit, while also demonstrating the ability to support our vision and add meaningful strategic value," Mike Hennessy, MJH Life Sciences CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US